Health Care & Life Sciences » Pharmaceuticals | La Jolla Pharmaceutical Co.

La Jolla Pharmaceutical Co.

La Jolla Pharmaceutical Co.
Stock Exchange NASDAQ Stock Market
EPS
$6.85
Market Cap
$259.88 M
Shares Outstanding
27.1 M
Public Float
23.14 M

Profile

Address
4550 Towne Centre Court
San Diego California 92121
United States
Employees -
Website http://www.lajollapharmaceutical.com
Updated 07/08/2019
La Jolla Pharmaceutical Co. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. Its products includes LJPC-501, LJPC-401, LJPC-30Sa and LJPC-30Sb. LJPC-501 is the proprietary formulation for angiotensin II.

Financials

View All

Kevin C. Tang
Chairman
George Francis Tidmarsh
President, CEO, Secretary & Director